Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc. (Nasdaq: ENSC) is a pharmaceutical company specializing in abuse-deterrent drug delivery technologies, operating in the healthcare and life sciences sector. The company filed this Form 10-Q on August 1, 2018, covering a quarterly reporting period that predates its entry into public markets via a special purpose acquisition vehicle. Ensysce completed a de-SPAC business combination with Leisure Acquisition Corp. in 2021, gaining Nasdaq access under the ENSC ticker. The company continues to operate as a publicly traded pharmaceutical developer focused on its proprietary abuse-deterrent platform. For comprehensive filing history, SPAC transaction analytics, and real-time coverage of Ensysce and thousands of other de-SPAC companies, sign up for full data access on SpacDesk.